Abstract
Data pertaining the population of Rochester (Minnesota) in the early eighties [1] are consistent with the end of the decline of stroke which was recorded in that area from 19–15 to 1974 [2]. However, the survival up to three days and the 30-day death of patients with cerebral infarction have never significantly decreased over the past four decades [3]. Therefore, stroke prevention, which appeared so effective until a few years ago, seems currently to have reached its limits, whereas available guidelines to treatment of acute brain ischemia are still needed now, as they were forty years ago.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Broderick, JP, Phillips, SJ, Whisnant, JP, O’Fallon, WM, Bergstral, EJ. (1989) “Incidence rate of stroke in the eighties: the end of the decline of stroke?” Stroke 20, 577–588.
Garraway, WM, Whisnant, JP, Furlan, AJ, Phillips, LH, Kurland, LT, O’Fallon, WM. (1979) “The declining incidence of stroke”, New Engl J Med 300, 499–452.
Garraway, WM, Whisnant, JP, Drury, I. (1983) “The changing pattern of survival following stroke”, Stroke 14, 699–702.
Caplan, LR, Stein, RW. (1986) “Stroke. A clinical approach”, Butterworths publisher.
Weinstein, PR, Anderson, GG, Teiles, DA. (1980) “Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cats”, Stroke 17, 318–324.
Lenzi, GLL, Frackowiack, RSJ, Jones, T. (1982) “Cerebral oxygen metabo1ism and blood f1ow in human cerebr a1 isohemic infarction”, J Cereb Blood Flow Metab 2, 321–335.
Vorstrup, S, Paulson, OB, Lassen, N. (1986) “Cerebral blood flow in acute and chronic ischemic stroke using Xenon-33 inhalation tomography”. Acta Neurol Scand 74, 439–451
Lenzi, GLL, Frackowiack, RSJ, Jones, T, Heather, JD, Lammertsma AA, Rhodes, CG, Pozzilli, C (1981) “CMR02 and CBF by 0xygen-15 inha1ation technique: resu1ts in normal volunteers and cerebrovascular patients”, Europ Neurol 20, 285–290.
Bozzao, L, Fantozzi, LM, Bastianello, S, Bozzao, A, Fieschi, C. (1989) “Early collateral blood supply and late parenchymal brain damage in pallents with middle cersbral artery occlusion”, Stroke 20, 735–740.
Fieschi, C, Argentino, C, Lenzi, G L, Sacchet, ML., Tom, D., Bozzao, L. (. 1989 ) “Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours” J Neurol Sci 91, 311–322.
Holmes, RA, Chaplin, SB, Rayston, FG et al (1985) “Cerebral uptake and retention of Tc-99m hexamethilpropyleneamine oxime (Tc-99m HM-PAO)”., Nucl. Med. Commun 6, 443–447.
Dalal, PM, (1965) “Angiographic observation on spontaneous clot lysis”, Lancet 1, 61–64.
Gurdjian, ES, Lindner, DW, Hardy, WG, Thomas, LM, (1961) “Completed stroke due to occlusive cerebrovascular disease. An analysis of 409 cases”, Neurology (Minn.) 11, 724–733.
Mohr, JP, Caplan, LR, Melski, JW, Goldstein, RJ, Duncan, GW. Kistler, JP, Pessin, MS, Blech, HI. (1978) “The Harvard Cooperative Stroke Registry: a prospective registry”, Neurology 28, 574–762.
Fisher, M. (1954) “Occlusion of the carotid arteries. Further experiences”, Arch Neurol Psychiat 72, 187–204.
Sloan, MA. (1987) “Thrombolysis and stroke. Past and future”, Arch Neurol 44, 748–768
The TPA-Acute Stroke Study Group. (1988) “An open multicenter study of the safety and efficacy of various doses of r-TPA in patients with acute stroke: preliminary results”, Stroke 19, 9.
GISSI. (1987) “Long-term effects of intravenous thrombolysis in acute myocardial, infarction: final report”, Lancet 1, 871–874.
Mohamed, AA, Gotoh, O, Graham, DI, Osborne, KA, McCulloch, J, Mendelow, AD, Teasdale GM, Harper MH. (1985) “Effect of pretreament with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion”, Ann Neurol 18, 705–711.
Gelmers, HJ, Gorter, K, De Weerdt, CJ, Wiezer, HJA. (1988) “A controlled trial of nimodipine in acute ischemic stroke”, N Engl J Med 318, 203–207.
Pozzilli, C, Di Piero, V, Pantano, P, Rasura, M., Lenzi, GL. (1981) “Inf1uence of nimodipine on cerebral blood flow in human cerebral ischaemia”, J Neurol 236, 199–202.
Siesjo, BK. (1981) “Cell damage in the brain. A speculative synthesis”, J Cereb Blood Flow Metab 1, 155–185.
Kuwaki, T, Satoh, H, Ono, T, Shibayama, F, Yamashita, T, Nishimura, T. (1989) “Nilvadipine attenuates ischemic degration of gerbil brain cytoscheletal proteins”, Stroke 20, 78–83.
Nakayama, H, Ginsberg, MD, Dietrich, WD, (1988) “(S)-Emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occasion in the rat”, Neuro1ogy 38, 1667–1673.
Rothmans, SM, Olney, JW. (1987) “Excitotoxicity and the NMDA receptor”, TINS 10, 299–302.
Astrup, J. (1982) “Energy-requiring cell functions in the ischemic brain”, J Neurosurg 56, 482–497.
Davis, CW, Daly, JW. (1980) “Activation of rat cerebral cortical 3′, 5′-cyclic nucleotide phosphodiesterase activity by ganglosides”, Mol Pharmacol 17, 206–211.
Greenberg, JH, Reivich, M,Urfoanics, R, Tanaka, K, Dora, E, Toffano, G. (1986) “The effect of GM1 on cerebral metabolism, microcirculation and histology in focal ischemia”, in Tettamanti, G et al. (eds.), Gangliosides and neuronal plasticity, Liviana Press, Padova, pp. 397–405.
Freed, WJ, De Medinaceli, L, Wyatt, RJ. (1985) “Promoting functional plasticity in the damaged nervous system”, Science 227, 1544–1552.
Doherty, P, Dickson, JG, Flanigan, TP, Walsh, FS. (1985) “Ganglioside GM1 does not initiate but enhances neurite regeneration of nerve growth factor-dependent sensory neurones”, J Neurochem 44, 1259–1265.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Fieschi, C., Toni, D., Sacchetti, M., Pantano, P., Millefiorini, E., Frontoni, M. (1990). Invasive treatment of acute stroke. In: Descovich, G., Gaddi, A., Magri, G., Lenzi, S. (eds) Atherosclerosis and Cardiovascular Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0731-7_91
Download citation
DOI: https://doi.org/10.1007/978-94-009-0731-7_91
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6814-7
Online ISBN: 978-94-009-0731-7
eBook Packages: Springer Book Archive